US Pharma MarketingEli Lilly invests in Oura to support patients on GLP-1 drugs
Eli Lilly takes an equity stake in smart ring maker Oura to back patients on its GLP-1 drugs; deal size undisclosed. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
Eli Lilly on Wednesday made an equity investment in wearable ring startup Oura as the drugmaker looks for ways to support patients taking its GLP-1 medications.
An Oura spokesperson declined to share the size of ...
Source: Endpoints News